Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.
The clinical effectiveness and cost to convert recent-onset atrial fibrillation or flutter to sinus after 3 to 4 weeks of anticoagulation with intravenous ibutilide was compared with direct-current cardioversion. The low success rate with ibutilide made direct-current cardioversion the more clinical and cost-effective method to restore sinus rhythm.
Murdock
D K
DK
Cardiovascular Associates of Northern Wisconsin, Wausau, USA.
Schumock
G T
GT
Kaliebe
J
J
Olson
K
K
Guenette
A J
AJ
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000191:economics / Q000628:therapy*; D001282:Atrial Flutter / Q000191:economics / Q000628:therapy*; D003362:Cost-Benefit Analysis; D004554:Electric Countershock / Q000191:economics*; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D017721:Hospital Costs; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D006278:Medicare / Q000191:economics; D013449:Sulfonamides / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States
D000889:Anti-Arrhythmia Agents; D013449:Sulfonamides; C067192:ibutilide